109-50-2 | Sigma-Aldrich

Product Information Sheet - 11585592001

3961. �DNA 20 �Ci 50 �Ci 100 �Ci [�32P]dCTP, 3000 Ci/mmol 25 ng 77% 1.1 × 109 75% 2 x 109 72% 2.8 × 109 incorporation dpm/�g 100 ng 79% 78% 7.3 × 108 77% 1.3 × 109

Product Information Sheet-11004760001

66% 0.9 × 109 65% 1.8 × 109 62% 2.6 × 109 incorporation dpm/ µg 100 73% 0.3 × 109 71% 0.7 × 109 68% 1.1 × 109

Product Information Sheet - 11585584001

λDNA 20 �Ci 50 �Ci 100 �Ci [�32P]dCTP, 3000 Ci/mmol 25 ng 77% 1.1 × 109 75% 2 × 109 72% 2.8 × 109 incorporation dpm/�g 100 ng 79% 3.2 ×108 78% 7.3 × 108 77% 1.3 × 109

Product Information Sheet-11585592001

λDNA [ng] 20 µCi 50 µCi 100 µCi α32 P-dCTP, 3,000 Ci/mmol 25 77% 1.1 × 109 75% 2 × 109 72% 2.8 × 109 incorporation dpm/µg 100 79% 78% 7.3 × 108

The Effective Use of Protein Kinase Inhibitors

15 19 0 1 77 8 53 94 89 87 116 91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103 69 109 20 105

The Effective Use of Protein Kinase Inhibitors

15 19 0 1 77 8 53 94 89 87 116 91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103 69 109 20 105

Sucrose Low in Nanoparticulate Impurities for Biopharmaceutical Formulations

g su cr os e] Batch 4Batch 3Batch 2Batch 1Before purification 0 2 × 109 4 × 109 6 × 109 8 × 109 Endotoxin (LPS) Factor C Factor B Activated Factor C Activated

Mobius® FlexReady Solution for Large Scale Clarification

/ 33m² 109 to 327 L/h/m² 109 to 163 L/h/m² Up to 109 L/h/m² 4 Description Specifications Pumps Brand: Model: Number: Flow range: Quattroflow™/Almatech 1200S 1 to 3 2 to 60LPM

A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling

(kg/yr) 551.11 761.53 546.10 819.14 1,092.19 1,365.24 1,638.29 Batches/yr 110 152 109 109 109 109 109 1:1 production/seed train ratio – 6 seed train 6b CoG’s ($/g) 65.88 75.03 75.03 54.67

A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling

(kg/yr) 551.11 761.53 546.10 819.14 1,092.19 1,365.24 1,638.29 Batches/yr 110 152 109 109 109 109 109 1:1 production/seed train ratio – 6 seed train 6b CoG’s ($/g) 65.88 75.03 75.03 54.67

Product Information Sheet - R7022

µCi/nmol) 2.2 x 109 = Factor to convert to dpm from :Ci 1.3 x 103 = Average molecular weight of the four dNMP’s (4x325) Using this procedure, a specific activity of 1 x 109 dpm/:g control DNA

Product Information Sheet - R9522

µCi/nmol) 2.2 x 109 = Factor to convert to dpm from :Ci 1.3 x 103 = Average molecular weight of the four dNMP’s (4x325) Using this procedure, a specific activity of 1 x 109 dpm/:g control DNA

Product Information Sheet - R7522

µCi/nmol) 2.2 x 109 = Factor to convert to dpm from µCi 1.3 x 103 = Average molecular weight of the four dNMP’s (4x325) Using this procedure, a specific activity of 1 x 109 dpm/µg control

Product Information Sheet - R9647

µC/nmol) 2.2 x 109 = Factor to convert to dpm from µCi 1.3 x 103 = Average molecular weight of the four dNMP’s (4x325) Using this procedure, a specific activity of 1 x 109 dpm/µg control DNA

Data Sheet - P1985

Proc. Natl. Acad. Sci. USA, 86, 4917 (1989). 2. Ross, R., et al., Proc. Natl. Acad. Sci. USA, 71, 1207 (1974). 3. Pierce, g., et al., J. Cell. Biol., 109, 429 (1989). 4. Ross, R., Arteriosclerosis, 1

Data Sheet - D0180

(DDC) Clone DDC-109 Mouse Ascites Fluid Catalog Number D0180 Product Description Monoclonal Anti-DOPA Decarboxylase (DDC) (mouse IgG2b isotype) is derived from the DDC-109 hybridoma produced

Flyer - Accurate cDNA levels for unbiased two-step qRT-PCR

Figure 2: Real-time PCR quantification (qPCR) of a 108-fold range of input RNA transcribed using the Transcriptor First Strand cDNA Synthesis Kit. A ten-fold dilution series of five copies to 5 x 109 copies

Improved Method for Adenovirus and Lentivirus Purification using the Fast-Trap™ Virus Purification and Concentration Kit

Double CsCl Gradient Amount crude adenovirus (ivp) 5.81 x 109 5.81 x 109 Amount purified adenovirus (ivp) 4.05 x 109 2.64 x 109 % virus recovery 70 45 Table 1. Adenovirus purification

Data Sheet - SRP5063

densitometry) Figure 2. Specific Activity of Typical Lot 81-109 nmole/min/mg Procedure Preparation Instructions Kinase Assay Buffer – 25 mM MOPS, pH 7.2, 12.5 mM glycerol 2-phosphate, 25 mM MgCl2

Attachment and Matrix Factors - V8379

filtration. 2) The resulting solution is slightly hazy and has a concentration of 40 µg/ml. 3) Use concentration for thrombospondin in culture has been reported in the range of 25 ng to 50 µg/ml depending

Attachment and Matrix Factors - V9881

filtration. 2) The resulting solution is slightly hazy and has a concentration of 40 µg/ml. 3) Use concentration for thrombospondin in culture has been reported in the range of 25 ng to 50 µg/ml depending

Attachment and Matrix Factors - V0132

filtration. 2) The resulting solution is slightly hazy and has a concentration of 40 µg/ml. 3) Use concentration for thrombospondin in culture has been reported in the range of 25 ng to 50 µg/ml depending

Protecting Protein Stability with a Novel Grade of Sucrose

development. After purification Before purification Batch 1 Batch 2 Batch 3 Batch 4 1×1010 8×109 6×109 0 4×109 2×109C on cn et ra ti on [p ar ti cl e/ g

Product Information Sheet - CKH200A

107 105 100-113 100 87-109 106 91-115 Average % of Expected 1:8 Range (%) 107 94-121 100 96-109 102 93-107 104 95-110

Data Sheet - 76307

1993). 2. Lunn, G. and Sansone, E.B., Appl. Biochem. Biotechnol., 48, 57 (1994). 3. Markwardt, F. et al., Thrombosis Research, 2, 343 (1973). 4. Lawson, W.B. et al., Folia Haematol., Leipzig, 109, 52 (

VirusExpress® 293 AAV Production Platform

Duration (Days) 50L BR SF-1 SF-2 N-1 Stage N Stage (Growth only) Figure 2. VirusExpress® 293 AAV Production Cells were cultured for batch growth in Mobius® 50 L Single-Use Bioreactors. Cells

ZIC-HILIC Separation of organophosphate nerve agent metabolites

200 Å (cat. no. 150454) Injection: 2 µL samples diluted in 70:30 acetonitrile/water v/v Detection: LC-MS in negative mode TIC from SIM m/z: 179 (+ fragment 109, 123, 137, 151, 191, 247 and 286)

Data Sheet - A2353

20 °C Synonyms: ATF-2 (AA 20-109), Maltose binding fusion protein (MBP); CRE-BP-1 (cAMP-responsive element binding protein-1) Product Description ATF-2 is a member of the leucine zipper protein

Prohibited Substances Korean

2019-29 n-부틸아민[n-Butylamine ; 109-73-9] 및 이를 25% 이상 함유한 혼합물 급성 흡입독성, 인화성 액체 2019-30 말로노니트릴[Malononitrile; 109-77-3] 및 이를 25% 이상 함유한 혼합물질 급성 흡입독성 2019-31 2-부틴-1,4-디올[2-Butyne-1,4-diol; 110-65-6] 및

Data Sheet - P3326

1315 (1987). 6. Ross, R., et al., Cell, 46, 155 (1986). 7. Pierce, G.F., et al., J. Cell Biol., 109, 429 (1989). 8. Ross, R., et al., Science, 248, 1009 (1990). 9. Betsholtz, C., et al., Nature, 320